Shares slide; Xero drops; energy regulator in rare U-turn over APA’s Basslink power cable; Cue Clothing CEO joins Myer.

Broker UBS believes the three-year rout of ASX healthcare stocks is near an end and it has promoted Cochlear and Resmed to ...

View the latest Neuren Pharmaceuticals Ltd. (NEU) stock price, news, historical charts, analyst ratings and financial information from WSJ.

The S&P/ASX 200 closed 8.4 points lower, down 0.10%. Really anything critical minerals was higher today, from antimony, to ...

The S&P 500 is on the cusp of a record high. That’s a remarkable change of events, since the index was on the brink of a bear ...

Shares of Neuren Pharmaceuticals Ltd (ASX:NEU) jumped over 10% on Thursday after the company announced a key development in ...

The market may be having a subdued start to the day but that hasn't stopped two ASX healthcare stocks from racing higher. The Neuren share price is up almost 12% to $14.00. This has been driven by ...

Corporate distress levels in Europe rose to a nine-month high in the three months to the end of May, an index compiled by law ...

CRSP launched its investable market indexes in 2010 in partnership with Vanguard, and Sauter led the implementation. The first of the indexes, the Total Market Index, was created to be “holistic, ...

A weakening US dollar, too, has fueled stocks. According to Ulrike Hoffmann-Burchardi, CIO of global equities for UBS Global Wealth, a depreciating dollar will persist in the second half of the year ...

Australian shares recovered early losses to trade flat at 2:10pm AEST.The benchmark S&P/ASX 200 index was flat at 8,559.2 by ...